Bhirde et al. conjugated both cisplatin and EGF to the surface of oxidized SWNTs, which endowed the nanosystem with active targeting ability through the interaction between EGF and EGFR overexpressed on tumor cells for enhanced antitumor efficacy of cisplatin [48]. Here, EGFR is linked to neoplasm.